Zhenhui Zhao

Ueruemqi, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Histopathological evaluation of RPL5 expression in triple-negative breast cancer: an integrated immunohistochemical and transcriptomic study.

Histopathological evaluation of RPL5 expression in triple-negative breast cancer: an integrated immunohistochemical and transcriptomic study.

Journal: European journal of histochemistry : EJH

Published: May 19, 2026

Efficacy and safety of dalpiciclib combined with endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer: a real-world study.

Efficacy and safety of dalpiciclib combined with endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer: a real-world study.

Journal: Frontiers in oncology

Published: January 16, 2026

Clinical efficacy and safety of pyrotinib as the first-line treatment of HER2-positive advanced breast cancer in Xinjiang Uygur Autonomous Region of China.

Clinical efficacy and safety of pyrotinib as the first-line treatment of HER2-positive advanced breast cancer in Xinjiang Uygur Autonomous Region of China.

Journal: Translational cancer research

Published: October 23, 2025

Clinical characteristics and prognosis of breast cancer patients with ovarian metastases.

Clinical characteristics and prognosis of breast cancer patients with ovarian metastases.

Journal: Frontiers in oncology

Published: June 04, 2025

Prognostic and Predictive Markers for Early Stage Triple-Negative Breast Cancer Treated With Platinum-Based Neoadjuvant Chemotherapy.

Prognostic and Predictive Markers for Early Stage Triple-Negative Breast Cancer Treated With Platinum-Based Neoadjuvant Chemotherapy.

Journal: Cancer medicine

Published: October 06, 2023

Clinicopathological observation and prognostic factors of invasive breast cancer with medullary in Xinjiang.

Clinicopathological observation and prognostic factors of invasive breast cancer with medullary in Xinjiang.

Journal: BMC medical informatics and decision making

Published: September 29, 2023

Pyrotinib combining with radiotherapy on breast cancer with brain metastasis.

Pyrotinib combining with radiotherapy on breast cancer with brain metastasis.

Journal: Experimental biology and medicine (Maywood, N.J.)

Published: December 19, 2022

Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases.

Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases.

Journal: Annals of medicine

Published: November 04, 2022

Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer.

Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer.

Journal: Breast cancer (Dove Medical Press)

Published: July 27, 2022

Clinical relevance of multi-drug resistance gene C3435T polymorphism in diffuse large B-cell lymphoma in Xinjiang.

Clinical relevance of multi-drug resistance gene C3435T polymorphism in diffuse large B-cell lymphoma in Xinjiang.

Journal: Medicine

Published: September 03, 2020

SNHG3 Functions as miRNA Sponge to Promote Breast Cancer Cells Growth Through the Metabolic Reprogramming.

SNHG3 Functions as miRNA Sponge to Promote Breast Cancer Cells Growth Through the Metabolic Reprogramming.

Journal: Applied biochemistry and biotechnology

Published: October 10, 2019

Engineered IL-7 Receptor Enhances the Therapeutic Effect of AXL-CAR-T Cells on Triple-Negative Breast Cancer.

Engineered IL-7 Receptor Enhances the Therapeutic Effect of AXL-CAR-T Cells on Triple-Negative Breast Cancer.

Journal: BioMed research international

Published: July 21, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026